Nguyen Quynh, Dinh Hoang V K, Phan Vien, Nguyen Nguyet, Nguyen Quan, Phan Van
Department of Internal Medicine, Logan Regional Medical Center, Logan, West Virginia.
Department of Internal Medicine, Cho Ray Hospital, Ho Chi Minh City, Vietnam.
AACE Endocrinol Diabetes. 2025 Apr 10;12(1):50-53. doi: 10.1016/j.aed.2025.02.004. eCollection 2025 May-Jun.
BACKGROUND/OBJECTIVE: Hypersensitivity reactions to medications often exhibit identifiable symptoms, yet their diagnosis can be challenging due to individual variability. Although hypersensitivity reactions to levothyroxine are rare, the presence of excipients in different formulations can trigger allergic manifestations. We present an unusual case of delayed hypersensitivity reaction characterized by isolated asymmetric periorbital edema, occurring within 1 to 2 months of being on levothyroxine therapy.
A 77-year-old woman, on thyroid hormone replacement for over 20 years, was taken off levothyroxine due to low thyroid-stimulating hormone. Within 2 months, her thyroid-stimulating hormone rose above 10 mIU/mL. Therefore, generic levothyroxine was restarted at the dose of 50 μg orally daily. After 1 month, she developed asymmetric bilateral periorbital edema without other symptoms such as rash, itching, redness, or fever. Discontinuing levothyroxine resolved the issue, but the reaction recurred with retrial of brand Synthroid. Despite the lack of typical allergy signs, the timing suggested a drug allergy. Switching to Tirosint capsules, with fewer inactive ingredients, successfully resolved the problem without further reactions.
Levothyroxine allergy is rare since its structure is identical to natural thyroxine. Allergic reactions are often caused by excipients such as fillers or dyes. Diagnosis can be challenging in atypical cases, and treatment may include desensitization if no suitable formulation is found.
This case underscores the importance of remaining vigilant for medication-induced hypersensitivity reactions and highlights the potential benefits of using formulations with minimal excipients when drug allergy is suspected, which can help us avoid complicated desensitization process.
背景/目的:药物过敏反应通常表现出可识别的症状,但由于个体差异,其诊断可能具有挑战性。尽管左甲状腺素过敏反应罕见,但不同制剂中辅料的存在可能引发过敏表现。我们报告一例不寻常的迟发性过敏反应病例,其特征为孤立性不对称眶周水肿,发生在左甲状腺素治疗1至2个月内。
一名77岁女性,接受甲状腺激素替代治疗20多年,因促甲状腺激素水平低而停用左甲状腺素。2个月内,她的促甲状腺激素升至10 mIU/mL以上。因此,重新开始口服通用左甲状腺素,剂量为每日50μg。1个月后,她出现双侧不对称眶周水肿,无皮疹、瘙痒、发红或发热等其他症状。停用左甲状腺素后问题得到解决,但重新试用品牌药优甲乐时反应复发。尽管缺乏典型的过敏体征,但发病时间提示药物过敏。改用活性成分较少的蒂洛辛胶囊成功解决了问题,未再出现进一步反应。
左甲状腺素过敏罕见,因为其结构与天然甲状腺素相同。过敏反应通常由填充剂或染料等辅料引起。非典型病例的诊断可能具有挑战性,如果找不到合适的制剂,治疗可能包括脱敏。
本病例强调了对药物引起的过敏反应保持警惕的重要性,并突出了在怀疑药物过敏时使用辅料最少的制剂的潜在益处,这有助于我们避免复杂的脱敏过程。